Xoma | XOMA - Operating Expenses

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $22.84M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Agenus USD -274.14M 80.46M Sep/2025
Agios Pharmaceuticals USD 141.54M 11.8M Dec/2025
Ardelyx USD 105.66M 6.4M Sep/2025
aTyr Pharma USD 26.94M 6.63M Sep/2025
BioMarin Pharmaceutical USD 807.82M 259.3M Sep/2025
Celldex Therapeutics USD 598.36M 533.78M Sep/2025
Curis USD -13.99M 7.38M Jun/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Emergent BioSolutions USD 555.9M 242.7M Jun/2023
Incyte USD 1.12B 3.53B Dec/2025
MacroGenics USD 67M 8M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Novartis USD 9.77B 401M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Prothena USD 42.18M 14.25M Sep/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Xoma USD 22.84M 1.67M Sep/2024